J Korean Med Assoc.  2006 May;49(5):457-463. 10.5124/jkma.2006.49.5.457.

Nonsurgical Treatment of Osteoarthritis

• Kim HC

• KMID: 2064954
• DOI: http://doi.org/10.5124/jkma.2006.49.5.457

Abstract

Osteoarthritis (OA) is the most common cause of localized or generalized joint pain in adults. OA is a condition that represents a complex of interactive degradative and reparative processes in the cartilage and bone with secondary inflammatory changes, particularly in the synovium. Although there is no known cure for OA, the treatment designed for the individual patients can reduce pain, maintain joint mobility, and limit the functional impairment. Guidelines for the treatment of OA include patient education and physical and occupational therapy. Weight loss has been shown to slow the progression of disease and to relieve symptoms in obese patients with OA of the knee. While low-impact exercise is beneficial, the adverse effects of high-impact and high-intensity activitiesy on the aggravation of OA have been documented. Most drug therapies with drugs are targeted to specific symptomsatic response. It is certainly worthwhile to initiate a trial of acetaminophen, known to be beneficial in OA patients with mild to moderate pain, on the basis of the risk-to-benefit ratio and cost. However, previous studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a better efficacy. The COX-2-specific inhibitors appear to be better tolerated, with a lower incidence of GI side effects, than comparator nonselective NSAIDs. However, the potential cardiovascular thrombotic events of these medications are considerable in the patients with hypertension or coronary artery disease. Although a number of agents are on the horizon, including glucosamine, chondroitin, diacerein, S-Adenosyl-LMethionine, and hyaluronan, no agent has been shown to have a disease-modifying OA drug (DMOAD) effect at this time.

Keyword

Osteoarthritis; Treatment; Nonsteroidal antiinflammatory drugs; Disease-modifying OA drug

MeSH Terms

Acetaminophen
Adult
Anti-Inflammatory Agents, Non-Steroidal
Arthralgia
Cartilage
Chondroitin
Coronary Artery Disease
Drug Therapy
Glucosamine
Humans
Hyaluronic Acid
Hypertension
Incidence
Joints
Knee
Occupational Therapy
Osteoarthritis*
Patient Education as Topic
Synovial Membrane
Weight Loss
Acetaminophen
Anti-Inflammatory Agents, Non-Steroidal
Chondroitin
Glucosamine
Hyaluronic Acid

Reference

1. Brenner SS, Klotz U, Alscher DM, Mais A, Lauer G, Schweer H, et al. Osteoarthritis of the knee-clinical assessment and inflammatory markers. Osteoarthritis Cartilage. 2004. 12:469–475.

2. Hochberg MC. Multidisciplinary integrative approach to treating knee pain in patients with osteoarthritis. Ann Intern Med. 2003. 139:731–733.

3. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 2000. 43:1905–1915.

4. FitzGerald GA. Coxibs and cardiovascular disease. N Engl J Med. 2004. 351:1709–1711.

5. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Williams HJ, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006. 354:795–808.